Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Colorectal Neoplasms 2Breast Diseases 2Thrombocythemia, Essential 1Polycythemia Vera 1Lymphedema 1Liver Neoplasms 1Hypogonadism 1Glioma 1Fatigue Syndrome, Chronic 1Eunuchism 1Adenoma 1

Interventions

testosterone undecanoate 3Testosterone 3testosterone 17 beta-cypionate 1Triptorelin Pamoate 1Testosterone Propionate 1Tamoxifen 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Orchiectomy 1Observation 1Methyltestosterone 1Mental Status and Dementia Tests 1Gonadotropin-Releasing Hormone 1Gels 1Drug Evaluation 1Clomiphene 1Castor Oil 1Blood Specimen Collection 1Anastrozole 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypogonadism × Drug Evaluation × Clear all
NCT04049331 2026-04-22

Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

Seattle Institute for Biomedical and Clinical Research

Phase 2 Active not recruiting
240 enrolled

Eunuchism, Hypogonadism, Fatigue Syndrome, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡